Preoperative Dual Immunotherapy Shows Promise in High-Risk Early HER2-Negative Breast Cancer
WASHINGTON — A combination of two immunotherapy drugs produced substantially higher rates of tumor eradication when added to chemotherapy before ...
WASHINGTON — A combination of two immunotherapy drugs produced substantially higher rates of tumor eradication when added to chemotherapy before ...
The ongoing debate in oncological treatment regarding the optimal approach for locally advanced rectal cancer (LARC) has taken a significant ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine